| Submission declined on 8 October 2024 by DoubleGrazing (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 7 October 2024 by Jamiebuba (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Jamiebuba 52 days ago. | |
Levent Akduman | |
|---|---|
 Levent Akduman at the Winning Pitch Challenge | |
| Born | |
| Nationality | Turkish-American |
| Education | Hacettepe University (MD) Gazi University (Residency in Ophthalmology) Washington University in St. Louis (Fellowships in Uveitis and Vitreoretinal Surgery) |
| Employer | Quantum Vision Centers |
| Known for | Development of the Staphyloma Supporting Device |
| Title | CEO of LA Eye |
| Awards | Winning Pitch Challenge (Retina category, 2022) |
| Website | Quantum Vision Centers Profile |
Levent Akduman is a Turkish-American ophthalmologist and entrepreneur recognized for his advancements in retinal surgery and the development of the Staphyloma Supporting Device.[1][2] He serves as a board-certified retina surgeon at Quantum Vision Centers in the St. Louis Metro East area and is the CEO of LA Eye.[2][3]
Early life and education
editLevent Akduman was born in Turkey and pursued his medical education at Hacettepe University in Ankara, where he earned his medical degree in 1988.[3] Following his graduation, he completed an internship and residency in Ophthalmology at Gazi University Medical School, concluding his residency in 1993.[4]
Dr. Akduman further specialized in the United States by undertaking fellowships at Washington University in St. Louis School of Medicine in 1996, focusing on Uveitis and Vitreoretinal Surgery.[4]
Career
editMedical Practice
editDr. Akduman is a board-certified ophthalmologist with over 30 years of experience. His professional interests include advanced cataract surgery, intraocular lens implantation, corneal transplantation, diabetic retinopathy, Usher syndrome, uveitis, vitrectomy, and diseases and treatments of the vitreous and retina.[5] He is affiliated with several professional organizations, including the American Academy of Ophthalmology, the American Board of Ophthalmology, the American Society of Cataract & Refractive Surgeons, the American Uveitis Society, and the Association of Research in Vision and Ophthalmology.[3]
Entrepreneurial Ventures
editDr. Akduman is the CEO of LA Eye, a company developing ophthalmic implants. His notable invention, the Staphyloma Supporting Device, is designed to address pathologic myopia by reshaping the posterior sclera to a more natural form and reducing axial length to treat or prevent blinding myopic maculopathy.[6]
In 2022, Dr. Akduman won the Winning Pitch Challenge in the Retina category for his invention, the Staphyloma Supporting Device, which was subsequently patented.[2] The implant has been successfully applied to patients in Turkey, demonstrating its potential in treating severe vision problems related to high myopia.[7]
Dr. Akduman is actively seeking FDA approval for his implant to facilitate its commercial production and global availability.[7]
Inventions and Patents
editDr. Akduman holds a patent for the Staphyloma Supporting Device, assigned to LA Eye. This device is a surgical implant designed to improve, support, or help preserve vision by altering the axial length or curvature of the eye.[8]
The Staphyloma Supporting Device is constructed as a unitary implant from a single base material, such as titanium alloy, ensuring structural rigidity and longevity. The device features a macular indenter plate that is wider than the implant body, and an anchor structure that is wider than the macular indenter plate. This design allows for a compound concavity scleral contact surface, which closely approximates the outer surface of the eye. The anterior radius of curvature works in tandem with a posterior radius of curvature that is smaller, enabling the restoration of macular shape and axial length.[9]
The design of the implant allows for better integration with the scleral surface, enhancing the stability and effectiveness of the surgical procedure. By restoring the natural curvature and reducing the axial length, the device aims to correct severe myopia and prevent associated retinal pathologies.[9]
Awards and honors
editIn 2022, Dr. Akduman was awarded first place in the 'Retina' category at the Winning Pitch Challenge for his invention, the Staphyloma Supporting Device.[2]
Personal life
editDr. Akduman resides in the United States and maintains strong ties with the Turkish medical community.[1] His work has significantly impacted patients suffering from severe myopia, offering new hope through advanced surgical interventions.[7]
References
edit- ^ a b @yirmidorttv (September 19, 2024). "[Turkish National News Interview Recording]" (Tweet) (in Turkish). Retrieved October 7, 2024 – via Twitter.
- ^ a b c d "Winning Pitch Challenge". Winning Pitch Challenge. 28 April 2022. Retrieved October 6, 2024.
- ^ a b c "About Dr. Levent Akduman". Quantum Vision Centers. Retrieved October 6, 2024.
- ^ a b "Levent Akduman, MD". Cox Health. Retrieved October 6, 2024.
- ^ "Overview". U.S. News & World Report. Retrieved October 6, 2024.
- ^ "MacularBuckle". MacularBuckle. Retrieved October 6, 2024.
- ^ a b c "Turkish doctor breaks new ground in vision". Hurriet (in Turkish). June 13, 2022. Retrieved October 7, 2024.
- ^ "Patents Assigned to LA EYE LLC". Justia Patents. Retrieved October 6, 2024.
- ^ a b 12070387, Levent Akduman, "Staphyloma supporting device and method for modifying the axial length and curvature of an eye", assigned to LA EYE LLC
External links
edit- Living people
- American ophthalmologists
- American physicians
- American medical researchers
- Turkish ophthalmologists
- Turkish physicians
- Turkish medical researchers
- Year of birth missing (living people)
- Washington University in St. Louis alumni
- Hacettepe University alumni
- Gazi University alumni
- American people of Turkish descent
- People from St. Louis